N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid

C47H51N10O10P — CID 167603730

IUPACN-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid
SMILESC=C1C[C@H]2C=Nc3cc(OCCCC(=O)Nc4cn(C)c(C(=O)Cc5cc(C(=O)Nc6cc(C(=O)n7ccc8ccc(NP(=O)(O)OCCOC)cc87)n(C)c6)n(C)c5)n4)c(C)cc3C(=O)N2C1
InChIInChI=1S/C47H51N10O10P/c1-28-16-34-23-48-36-22-41(29(2)17-35(36)46(61)57(34)24-28)66-13-7-8-43(59)50-42-27-55(5)44(51-42)40(58)19-30-18-38(53(3)25-30)45(60)49-33-21-39(54(4)26-33)47(62)56-12-11-31-9-10-32(20-37(31)56)52-68(63,64)67-15-14-65-6/h9-12,17-18,20-23,25-27,34H,1,7-8,13-16,19,24H2,2-6H3,(H,49,60)(H,50,59)(H2,52,63,64)/t34-/m0/s1
InChIKeyKCEHKFOEKMBSBK-UMSFTDKQSA-N
MW946.96 g/mol
LogP6.19
Rot. Bonds18

About N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid

N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid (PubChem CID 167603730) has the molecular formula C47H51N10O10P and a molecular weight of 946.96 g/mol. Its IUPAC name is N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid.

Molecular Properties

Compound NameN-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid
PubChem CID167603730
Molecular FormulaC47H51N10O10P
Molecular Weight946.96 g/mol
Exact Mass946.35
IUPAC NameN-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid
SMILESC=C1C[C@H]2C=Nc3cc(OCCCC(=O)Nc4cn(C)c(C(=O)Cc5cc(C(=O)Nc6cc(C(=O)n7ccc8ccc(NP(=O)(O)OCCOC)cc87)n(C)c6)n(C)c5)n4)c(C)cc3C(=O)N2C1
InChIInChI=1S/C47H51N10O10P/c1-28-16-34-23-48-36-22-41(29(2)17-35(36)46(61)57(34)24-28)66-13-7-8-43(59)50-42-27-55(5)44(51-42)40(58)19-30-18-38(53(3)25-30)45(60)49-33-21-39(54(4)26-33)47(62)56-12-11-31-9-10-32(20-37(31)56)52-68(63,64)67-15-14-65-6/h9-12,17-18,20-23,25-27,34H,1,7-8,13-16,19,24H2,2-6H3,(H,49,60)(H,50,59)(H2,52,63,64)/t34-/m0/s1
InChIKeyKCEHKFOEKMBSBK-UMSFTDKQSA-N
XLogP6.19
TPSA234.64 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds18
Heavy Atoms68
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500946.96
LogP ≤ 56.19
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid?
The IUPAC name of N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid (CID 167603730) is N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid.
What is the SMILES notation for N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid?
The canonical SMILES for N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid is C=C1C[C@H]2C=Nc3cc(OCCCC(=O)Nc4cn(C)c(C(=O)Cc5cc(C(=O)Nc6cc(C(=O)n7ccc8ccc(NP(=O)(O)OCCOC)cc87)n(C)c6)n(C)c5)n4)c(C)cc3C(=O)N2C1.
What is the InChIKey of N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid?
The InChIKey is KCEHKFOEKMBSBK-UMSFTDKQSA-N. The full InChI is InChI=1S/C47H51N10O10P/c1-28-16-34-23-48-36-22-41(29(2)17-35(36)46(61)57(34)24-28)66-13-7-8-43(59)50-42-27-55(5)44(51-42)40(58)19-30-18-38(53(3)25-30)45(60)49-33-21-39(54(4)26-33)47(62)56-12-11-31-9-10-32(20-37(31)56)52-68(63,64)67-15-14-65-6/h9-12,17-18,20-23,25-27,34H,1,7-8,13-16,19,24H2,2-6H3,(H,49,60)(H,50,59)(H2,52,63,64)/t34-/m0/s1.
What are the key properties of N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid?
N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid has a molecular weight of 946.96 g/mol, XLogP of 6.19, 18 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-[[4-[2-[4-[4-[[(6aS)-2-methyl-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazol-2-yl]-2-oxoethyl]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indol-6-yl]-(2-methoxyethoxy)phosphonamidic acid is sourced from PubChem (CID 167603730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).